UC Santa Barbara

Campus Notes:

  Over 90% of FY96 income was attributable to earned royalties for two commercialized inventions, both among the University’s “Top 25” (see Exhibit 12). Due to production problems experienced by the licensee, income on the Marine Anti-inflammatory decreased by nearly 70% from FY95 to FY96. UCSB’s share of this income, which is split evenly with the San Diego campus, decreased by $236,000. However, total income remained stable due to a $174,000 increase in income received for the Atomic Force Microscope, together with increased minimum royalties received for other inventions.

  The number of disclosures received from UCSB investigators increased by two-thirds from FY95 to FY96. This was not yet reflected in patent filings or costs, which actually decreased. It should be noted that the large number of secondary filings in FY95 were motivated by patent law changes related to GATT.

  OTT operating expenses increased by $17,000 because licensing professionals spent a larger portion of their time managing UCSB inventions. Inventor share payments also increased marginally from FY95 to FY96, reflecting an increase in income from FY94 to FY95. The State share decreased slightly.

  A combination of all the above factors resulted in a 21% ($23,000) decrease in net income from FY95 to FY96.

PORTFOLIO ACTIVITY